Human BTLA/BTLA1/CD272 ORF/cDNA clone-Lentivirus plasmid (NM_181780.3)

Cat. No.: pGMLP001882
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human BTLA/BTLA1/CD272 Lentiviral expression plasmid for BTLA lentivirus packaging, BTLA lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to BTLA/CD272/BTLA/BTLA1 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $517.5
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP001882
Gene Name BTLA
Accession Number NM_181780.3
Gene ID 151888
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 870 bp
Gene Alias BTLA1,CD272
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGAAGACATTGCCTGCCATGCTTGGAACTGGGAAATTATTTTGGGTCTTCTTCTTAATCCCATATCTGGACATCTGGAACATCCATGGGAAAGAATCATGTGATGTACAGCTTTATATAAAGAGACAATCTGAACACTCCATCTTAGCAGGAGATCCCTTTGAACTAGAATGCCCTGTGAAATACTGTGCTAACAGGCCTCATGTGACTTGGTGCAAGCTCAATGGAACAACATGTGTAAAACTTGAAGATAGACAAACAAGTTGGAAGGAAGAGAAGAACATTTCATTTTTCATTCTACATTTTGAACCAGTGCTTCCTAATGACAATGGGTCATACCGCTGTTCTGCAAATTTTCAGTCTAATCTCATTGAAAGCCACTCAACAACTCTTTATGTGACAGATGTAAAAAGTGCCTCAGAACGACCCTCCAAGGACGAAATGGCAAGCAGACCCTGGCTCCTGTATAGTTTACTTCCTTTGGGGGGATTGCCTCTACTCATCACTACCTGTTTCTGCCTGTTCTGCTGCCTGAGAAGGCACCAAGGAAAGCAAAATGAACTCTCTGACACAGCAGGAAGGGAAATTAACCTGGTTGATGCTCACCTTAAGAGTGAGCAAACAGAAGCAAGCACCAGGCAAAATTCCCAAGTACTGCTATCAGAAACTGGAATTTATGATAATGACCCTGACCTTTGTTTCAGGATGCAGGAAGGGTCTGAAGTTTATTCTAATCCATGCCTGGAAGAAAACAAACCAGGCATTGTTTATGCTTCCCTGAACCATTCTGTCATTGGACCGAACTCAAGACTGGCAAGAAATGTAAAAGAAGCACCAACAGAATATGCATCCATATGTGTGAGGAGTTAA
ORF Protein Sequence MKTLPAMLGTGKLFWVFFLIPYLDIWNIHGKESCDVQLYIKRQSEHSILAGDPFELECPVKYCANRPHVTWCKLNGTTCVKLEDRQTSWKEEKNISFFILHFEPVLPNDNGSYRCSANFQSNLIESHSTTLYVTDVKSASERPSKDEMASRPWLLYSLLPLGGLPLLITTCFCLFCCLRRHQGKQNELSDTAGREINLVDAHLKSEQTEASTRQNSQVLLSETGIYDNDPDLCFRMQEGSEVYSNPCLEENKPGIVYASLNHSVIGPNSRLARNVKEAPTEYASICVRS

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Biosimilar GMP-Bios-ab-258 Pre-Made Icatolimab biosimilar, Whole mAb, Anti-BTLA Antibody: Anti-CD272 therapeutic antibody
    Target Antibody GM-Tg-g-T68001-Ab Anti-BTLA/ BTLA1/ CD272 monoclonal antibody
    Target Antigen GM-Tg-g-T68001-Ag BTLA VLP (virus-like particle)
    ORF Viral Vector pGMLP001882 Human BTLA Lentivirus plasmid
    ORF Viral Vector vGMLP001882 Human BTLA Lentivirus particle


    Target information

    Target ID GM-T68001
    Target Name BTLA/CD272
    Gene Group Identifier
    （Target Gene ID in Homo species)         		151888
    Gene ID 100071491 (Equus caballus), 101088181 (Felis catus), 151888 (Homo sapiens), 208154 (Mus musculus)
    407756 (Rattus norvegicus), 487975 (Canis lupus familiaris), 531767 (Bos taurus), 708202 (Macaca mulatta)
    Gene Symbols & Synonyms BTLA,Btla,BTLA1,CD272,A630002H24
    Target Alternative Names A630002H24,B- and T-lymphocyte attenuator,B- and T-lymphocyte-associated protein,BTLA,BTLA1,Btla,CD272
    Uniprot Accession Q6PNM1,Q7TSA3,Q7Z6A9
    Additional SwissProt Accessions: Q7Z6A9,Q7TSA3,Q6PNM1
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target, INN Index
    Disease
    Disease from KEGG
    Gene Ensembl ENSECAG00000016436, ENSG00000186265, ENSMUSG00000052013, ENSCAFG00845029395, ENSBTAG00000011871, ENSMMUG00000014231
    Target Classification Checkpoint-Immuno Oncology


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.